Lurie Cancer Center Completes Dosing of First Patient with LIXTE’s LB-100 in Combination with GSK’s Immunotherapy Dostarlimab --PASADENA, ...

LIXTE Biotechnology (LIXT) has added the Robert H. Lurie Comprehensive Cancer Center of Northwestern University as a second site in a clinical ...

Lurie Cancer Center initiates trial combining LIXTE's LB-100 and GSK's Dostarlimab for ovarian clear cell cancer treatment. LIXTE Biotechnology Holdings, Inc. has announced that the Robert H.

Lurie Comprehensive Cancer Center (Lurie Cancer Center) of Northwestern University as a second site in a clinical trial combining the Company’s proprietary compound LB-100 with GSK’s ...

Oncology Research Program (ORP) today announced new funding aimed at advancing clinical research in gastrointestinal cancers.

Lurie Comprehensive Cancer Center (Lurie Cancer Center) of Northwestern University as a second site in a clinical trial combining the Company's proprietary compound LB-100 with GSK's Dostarlimab to ...

Lurie Comprehensive Cancer Center of Northwestern University. “Innovative research is essential for driving progress in cancer care.” - Dr. Denlinger, Chief Executive Officer, NCCN ...

Historically, cancer care largely focused on the fight for survival. Now, thanks to advancements in screening and treatment, many patients are living decades beyond their diagnosis.

Meghan Markle shared a series of snapshots of her weekend activities at her home in Montecito, California, and gave a nod to ...

Meghan Markle social media presence continues to grow as the Duchess of Sussex gears to launch her lifestyle brand.Prince ...